Recent advances in tissue engineering technologies have highlighted the ability to create functional liver systems using isolated hepatocytes in vivo. Considering the serious shortage of donor livers that can be used for hepatocyte isolation, it has remained imperative to establish a hepatocyte propagation protocol to provide highly efficient cell recovery allowing for subsequent tissue engineering procedures. Donor primary hepatocytes were isolated from human α-1 antitrypsin (hA1AT) transgenic mice and were transplanted into the recipient liver of urokinase-type plasminogen activator-severe combined immunodeficiency (uPA/SCID) mice. Transplanted donor hepatocytes actively proliferated within the recipient liver of the uPA/SCID mice. At week 8 or later, full repopulation of the uPA/SCID livers with the transplanted hA1AT hepatocytes were confirmed by blood examination and histological assessment. Proliferated hA1AT hepatocytes were recovered from the recipient uPA/SCID mice, and we generated hepatocyte sheets using these recovered hepatocytes for subsequent transplantation into the subcutaneous space of mice. Stable persistency of the subcutaneously engineered liver tissues was confirmed for up to 90 days, which was the length of our present study. These new data demonstrate the feasibility in propagating murine hepatocytes prior to the development of hepatic cells and bioengineered liver systems. The ability to regenerate and expand hepatocytes has potential clinical value whereby procurement of small amounts of tissue could be expanded to sufficient quantities prior to their use in hepatocyte transplantation or other hepatocyte-based therapies. 429 430 OHASHI ET AL.
INTRODUCTION
been largely predicated on two key factors. First, the creation of a vascularized platform using a growth factor-releasing device at the target subcutaneous site prior Liver tissue engineering using primary hepatocytes presents the opportunity to create a de novo liver sys-to the transplantation of the donor hepatocytes (30) . The prevascularization process plays a pivotal role in the sur-tem, which can lead to a new therapeutic modality towards the treatment of various liver diseases (4,10, vival of the transplanted hepatocytes by providing an adequate blood supply to these transplanted cells, due to 15, 18, 28) and may have the potential to obviate the need for organ liver transplantation. In fact, hepatocyte trans-their high metabolic activities that require an active nutrient supply and waste exchanges (13, 16) . The sec-plantation into the liver of a recipient patient has proven to be effective in some experimental and clinical settings ond factor is the creation of uniform hepatocyte sheets using the isolated individual donor hepatocytes in cul-(3,10, 14, 20, 21, 24, 26) .
We have recently developed a novel approach for ture (17) . The in vitro created hepatocyte sheets maintain their intercellular communications (e.g., desmosomes and engineering a functional ectopic liver system within the subcutaneous space in mice (17) . The engineered liver bile canaliculi) and exhibit other essential cellular microstructures to document their continued hepatocyte systems have been shown to persist for at least 200 days, and the persistency of the de novo engineered tissue has phenotype and functionality. Recent studies by our group has shown that combining these two factors in transgene in each SCID mouse was genotypically confirmed by PCR as described previously (23) . Experi-which the in vitro-generated hepatocyte sheets were transplanted within a prevascularized subcutaneous site mental protocols were developed in accordance with the guidelines of the local animal committees at HPIIST, potentiated the formation of a fully functional, long-lasting two-dimensional liver systems (17) . Moreover, a PhoenixBio, Co., Ltd., and Tokyo Women's Medical University. Mice were placed in cages within a tempera-more spatially complex, three-dimensional liver systems could be successfully achieved by stratifying additional ture-controlled room with a 12-h light/12-h dark cycle as well as ad libitum access to food and water. hepatocyte sheets in the subcutaneous space (17) . The confirmed functionality of the engineered liver system Hepatocyte Isolation and Purification includes liver-specific protein productions, chemical uptake and subsequent metabolizing enzyme expressions, Hepatocytes were isolated from hA1AT-TG mice or hA1AT hepatocyte-repopulated uPA/SCID mice using a and regenerative growth (17) .
Although this approach has shown considerable modified two-step collagenase perfusion method as previously described (5, 11, 12, 16, 17, 30) . Briefly, the livers promise in recent years, there are several hurdles that need to be overcome for continual advancement to occur were primarily perfused with Hank's balanced salt solution (HBSS) (Sigma, St. Louis, MO) containing 0.09% using hepatocyte-based technologies. Most notably, the potential lack of donor hepatocytes could become an EGTA followed by a second perfusion using HBSS containing 0.03% collagenase (Sigma) and 5 mM CaCl 2 . issue depending on the abundance of the liver mass obtained for this procedure, since isolated hepatocytes Isolated cells were filtered through a nylon mesh membrane and hepatocytes were then purified by slow speed lose their ability to actively proliferate following transfer to culture conditions (9, 14) . For this reason, an efficient centrifugation at 50 × g for 5 min followed by Percoll (GE Healthcare, Buckinghamshire, UK) isodensity puri-method to propagate donor hepatocytes needs to be established. However, we and others have shown that fication. The viabilities of the isolated mouse hepatocytes were determined by trypan blue exclusion test. In primary donor hepatocytes can be successfully proliferated in vivo following transplantation in the livers of studies of hA1AT hepatocyte transplantation to the uPA/ SCID mice, experiments were conducted only when the several mouse models, including the urokinase-type plasminogen activator-severe combined immunodefi-hA1AT hepatocyte viabilities exceeded 95%. ciency (uPA/SCID) transgenic mice (1,6,7, 19, 22, 23) .
Transplantation of hA1AT Hepatocytes for Propagation Towards this end, we have designed the present study in the uPA/SCID Livers to determine whether primary donor mouse hepatocytes transplanted into the livers of uPA/SCID recipient mice Isolated hA1AT hepatocytes were resuspended with serum-free Dulbecco's modified Eagle medium (DMEM) can be efficiently propagated in vivo for subsequent downstream utilization as a valuable source for the cre-(Sigma) to a final ratio of 1.5 × 10 7 hepatocytes/ml. A total of 5 × 10 5 viable hepatocytes were transplanted ation of hepatocyte cell sheets. The efficacy in the generation of hepatocyte cell sheets in the prevascularized into the liver of uPA/SCID mice using an infusion technique into the inferior splenic pole as described pre-subcutaneous space of mice and their persistent biological function(s) will be investigated.
viously (22, 23, 31) .
MATERIALS AND METHODS

Creation of Two-Dimensional Hepatic Tissue Sheets Animals
The creation of hepatocyte sheets was performed as described previously (17) . Briefly, hA1AT hepatocytes Transgenic mice expressing human α-1 antitrypsin (hA1AT) under the hepatocyte-specific promoter (hA1AT-were isolated from hA1AT mouse livers and hA1AT hepatocyte-repopulated uPA/SCID livers were plated on FVB/N, H-2 q ; kindly provided by Dr. Bumgardner, Ohio State University, Columbus, OH) (2) at 13 weeks of age the temperature-responsive polymer [poly(N-isopropylacrylamide)]-coated (PIPAAm) dishes (UpCell, 35 mm, were used as donors for hepatocyte isolation. Wild-type female FVB/N mice (11-12 weeks of age), which were CellSeed, Tokyo, Japan) at a density of 8 × 10 5 cells/ dish. Cell culture was performed at 37°C. Three days syngenic to the hA1AT-FVB/N, were used as the recipient animals. hA1AT transgenic (hA1AT-TG) and FVB/ later, when the plated hepatocytes reached confluency, the cultured hepatocytes were detached from the culture N mice were maintained in the Animal Center at Tokyo Women's Medical University. uPA/SCID mice used in dish and harvested as a uniformly connected tissue sheet by lowering the culture temperature to 20°C for 15 min. the hepatocyte propagation experiments were generated at Hiroshima Prefectural Institute of Industrial Science
The harvested hepatocyte tissue sheets were attached to a support membrane (CellShifter, CellSeed) for subse-and Technology (HPIIST) and PhoenixBio, Co. Ltd. as described previously (22,23,31). Presence of the uPA quent transplantation.
Hepatocyte Sheet-Based Liver Tissue Engineering Procedure
Prior to the liver tissue engineering procedure, the basic fibroblast growth factor (bFGF)-releasing device was inserted into the subcutaneous space on the back of FVB/N mice as described previously (17, 30) . Ten days after the device insertion, a highly vascularized subcutaneous platform was developed. Right before the hepatocyte sheet transplantation, an L-shaped skin incision was made to open the vascularized platform followed by removal of the device. The harvested hepatocyte sheet was transplanted onto the vascularized platform with the support membrane. Approximately 5 min later, the support membrane was removed while leaving the hepatocyte sheet in vivo and procedure was finalized by closing the skin wound.
Enzyme-Linked Immunosorbent Assay (ELISA)
Propagation status of the hA1AT hepatocytes in the uPA/SCID livers and functional volume of the liver tissues engineered in the FVB/N mice were assessed by measuring the recipient serum hA1AT concentrations by ELISA. The ELISA used an antibody against hA1AT (DiaSorin, Stillwater, MN) coupled with a secondary goat IgG antibody conjugated with horseradish peroxidase (Resewarch Diagnostics Inc., Flander, NJ) as previously described (10).
Histological Analyses
In some recipient uPA/SCID mice, livers were harvested at 8 weeks after hA1AT hepatocyte transplantation. Portions of subcutaneous tissues of FVB/N mice containing engineered liver tissues were harvested 90 days after hepatocyte sheet transplantation. Liver specimens and subcutaneous tissues were fixed in 10% buffered formalin and embedded in paraffin. The specimens were sliced into 5-µm-thick sections, which were processed for hematoxylin & eosin (H&E) staining or immunohistochemical staining. Immunohistochemical staining was performed using the avidin-biotin complex method with the rabbit polyclonal hA1AT-specific antibody (1:200, YLEM, Roma, Italy). For the cellular gly- ues were determined by a Student's t-test. A probability value of p < 0.05 was considered statistically significant.
RESULTS
Proliferation of hA1AT Allogenic Hepatocytes in uPA/SCID Livers
Hepatocytes isolated from 13-week-old hA1AT-TG mouse were transplanted into uPA/SCID mice (n = 5). Serum hA1AT was detected, which ranged between 8,000 and 14,000 ng/ml, in all of the five recipient uPA/ SCID mice at day 2 after transplantation. Following measurements after day 2 showed continuous increases in the serum hA1AT levels through to week 8 (Fig. 1A) .
In four out of the five recipient mice, the serum hA1AT levels reached the same levels as detected in normal hA1AT-TG mice. The elevated serum hA1AT levels persisted throughout the observation period until the end of the study at week 18.
At random, we selected some of the recipient uPA/ SCID mice to assess the state of hA1AT hepatocytes repopulation in the liver samples obtained from the uPA/ SCID mice at week 8 after transplantation. hA1AT staining of native liver samples of nontransplanted uPA/ SCID mouse (for control) did not show any positively stained cells, confirming the staining specificity for hA1AT ( Fig. 1B) . In contrast, week 8 liver samples of the recipient uPA/SCID mice showed that hA1AT hepatocytes had invaded the liver throughout the organ (Fig.  1C) , indicating that the uPA/SCID livers had been fully repopulated with the transplanted hA1AT hepatocytes during the 8-week period after transplantation.
Isolation of Repopulated hA1AT Hepatocytes From uPA/SCID Livers and Creation of Hepatocyte Sheet
Our confirmation that there was full repopulation of uPA/SCID livers with hA1AT hepatocytes after week 8 allowed us to continue to determine whether these donor repopulated hepatocytes could be a viable option for isolation and recovery to develop them in the hepatocyte sheet protocol. To achieve this goal, we isolated and recovered the repopulated hA1AT hepatocytes form one uPA/SCID recipient at week 12. After the Percoll isodensity centrifugation step, 14.5 × 10 6 viable hepatocytes were obtained. These recovered hA1AT hepatocytes (recovered hepatocytes) were then plated on the PIPAAm culture dishes at a density of 0.75 × 10 6 per 35-mm dish as previously described (17) (Fig. 2) . We hepatocytes from the uPA/SCID livers that had been repopualso isolated hA1AT hepatocytes (fresh hepatocytes) wells in each group, no statistically significant differences between groups). At day 3 of the culturing protocol, the recovered hepatocytes were found to reach confluence. Lowering the culture temperature from series of developments is the creation of a uniform hepatocyte sheet using the PIPAAm culture dishes (17, 27) . 37°C to 20°C for 15 min resulted in the spontaneous detachment of the cultured hepatocytes from the culture The present study demonstrated that the hepatocytes recovered from the propagated livers of uPA/SCID mice plates as a uniform cell sheet.
were adhesive to the PIPAAm dish surfaces, and Liver Tissue Engineering Using Hepatocyte Sheet appeared to be at a similar efficiency of newly isolated Made of Recovered Hepatocytes primary hepatocytes that have not been previously isolated and propagated. The attached hepatocytes in the The recovered hepatocyte sheet was then used for liver tissue engineering with the FVB/N mice using a present study showed natural cell extension and became confluent by day 3 of culture. These cells showed the similar procedure as previously described (17) . Hepatocyte sheet was transplanted to the subcutaneous site that same morphological alterations associated with normal primary hepatocytes. This morphological similarity sug-had been prevascularized following the insertion of a bFGF-releasing device. Functional activity of the engi-gests that the microtubules and microfilaments were likely intact in the recovered hepatocytes. neered liver tissues was assessed by measuring serum hA1AT levels in the recipient FVB/N mice. As shown This study as well as previous studies by our group have shown that hepatocyte sheets can be obtained by in Figure 3A , recipient mice showed stable and persistent serum hA1AT levels (ranged between 2,000 and natural detachment of the primary cultured hepatocytes from the PIPAAm culture surfaces through a simple 5,000 ng/ml), suggesting that the engineered liver tissues could be viable and stably maintained throughout change in the ambient temperature for a brief period of time (17) without the need for any proteolytic enzyme the 90-day experimental period.
Subcutaneous tissue samples taken 90 days after the treatment (28,29). This simple cell harvesting approach does not damage the cell-to-cell contact allowing for the tissue engineering procedure were assessed for histological examination. H&E staining and hA1AT immuno-retention of the intricate cell-cell intercommunication systems (i.e., bile canaliculi, desmosomes, gap junc-staining revealed that liver tissues were engineered in the subcutaneous space with the hepatocyte-specific tions) (17) . Although the ultrastructural examination was not performed in the present study, it is reasonable to phenotypes (Fig. 3B, C) . PAS staining revealed that the engineered liver tissues were positive for the function of postulate that the hepatocyte sheet made of the recovered hepatocytes possessed intercellular communica-glycogen synthesis and storage (Fig. 3D) . Negative signals in the PAS staining on salivary amylase-pretreated tions previously observed in our system using newly isolated hepatocytes considering that these functional samples confirmed staining specificity for cellular glycogen ( Fig. 3E ). It is important to note that there was intercellular communications are important in maintaining the structure of monolayered hepatocyte sheet. The no evidence of tumor formation observed in any of the engineered tissues.
integrity of the hepatocyte sheet using the recovered donor hepatocytes is similar to that of de novo isolated DISCUSSION cells, and is readily transferable to a support membrane for the transplantation process. The present study describes an in-mouse hepatocyte propagation system by which uPA/SCID mouse livers
We have previously reported that the uPA/SCID mice have the innate property to actively proliferate donor pri-were found to fully reconstitute transplanted allogeneic mouse primary hepatocytes. This full reconstitution mary hepatocytes of xenogenic origin, including human hepatocytes, following transplantation into the liver (22, event was conducted by active and continuous hepatocyte proliferation as evidenced by the progressive 23,31). The functional preservation of the human hepatocytes during their active proliferation phase in the increase in the hA1AT serum levels of the recipient uPA/SCID mice and massive occupation of hA1AT uPA/SCID livers had been previously established as determined by the production of a hepatocyte-specific staining-positive hepatocytes in the recipient livers. The present study also showed that these propagated donor coagulation factor IX (FIX) (23) . As an extension of the FIX findings, we have recently found that human hepatocytes were able to be recovered, cultured, and subsequently used in the creation of hepatocyte sheets.
hepatocytes in the uPA/SCID livers can maintain their cellular machinery to produce other hepatocyte-specific The de novo generated hepatocytes sheets were able to be transplanted into a prevascularized subcutaneous coagulation factors and anticoagulation factors (unpublished data). The availability of the propagated human space resulting in the successful engineering of an ectopic functional liver tissue.
hepatocytes in the uPA/SCID system for in vitro analyses was established in an earlier study by Yoshitsugu et We have established several innovative experimental approaches to create functional liver system in vivo al. (31). Since the recovered human hepatocytes can be cultured and express various drug-metabolizing enzymes, (5,11-13,16,17,30). One of the key technologies in our it was demonstrated that these recovered hepatocytes liver procedure, and can be a potential valuable method to generate a new source of hepatocytes for hepatocyte-could be a valuable cell source for the study of a variety of liver functions (31). From these previous studies as based therapies. well as the findings in our current study, we suggest that 
